Re: Fertility Preservation for Men with Testicular Cancer: Is Sperm Cryopreservation Cost Effective in the Era of Assisted Reproductive Technology?

2018 ◽  
Vol 200 (5) ◽  
pp. 930-931
Author(s):  
Craig Niederberger
Andrologia ◽  
2017 ◽  
Vol 50 (1) ◽  
pp. e12833 ◽  
Author(s):  
A. Reignier ◽  
J. Lammers ◽  
C. Splingart ◽  
D. Redhead ◽  
J. J. Labat ◽  
...  

2021 ◽  
Vol 2 ◽  
pp. 49-54
Author(s):  
Yasotha Thirupathi ◽  
Pratheesh Mankuzhy ◽  
Vikash Chandra ◽  
G. Taru Sharma

Cryopreservation plays a central role in assisted reproductive technology (ART) by allowing in vitro fertilization (IVF) cycle segmentation, banking of supernumerary gametes, embryos, and fertility preservation. The identification of viral receptors on gametes and embryos raises serious concerns for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients who are interested in preserving fertility. The complications caused by the SARS-CoV-2 on IVF and embryo safety are yet to be explored. Scanty information is available so far regarding the risk of cryopreservation of biological materials used in ART. Here, we highlight the risks of cryopreservation in ART and safety measures to follow amidst the COVID-19 pandemic.


2014 ◽  
Vol 73 (3) ◽  
pp. 150-153
Author(s):  
Chuyu Hayashi ◽  
Kaori Matsumoto ◽  
Erina Kato ◽  
Go Ichikawa ◽  
Fumihisa Chishima ◽  
...  

Zygote ◽  
2012 ◽  
Vol 22 (2) ◽  
pp. 132-137 ◽  
Author(s):  
Dun-Gao Li ◽  
Yan Zhu ◽  
He-Ping Li ◽  
Xue-Jin Chen ◽  
Man-Xi Jiang

SummaryThe maintenance and preservation of strains of mice used in biomedical research presents a unique challenge to individual investigators and research institutions. The goal of this study was to assess a comprehensive system for mouse strain conservation through a combination of natural mating, sperm cryopreservation and assisted reproductive technology. Our strategy was based on the collection and cryopreservation of fresh epididymal sperm from male mice by semi-vasectomy; these mice were then naturally mated for breeding purposes. If no satisfactory results were obtained from natural breeding, then the cryopreserved sperm were used for in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI); resultant embryos were then transferred into pseudopregnant-recipient female mice. Our results show that some semi-vasectomized mouse strains can be conserved by natural breeding, and that sterile males can be compensated for through the use of IVF and ICSI technology. As such, we believe this system is suitable for the purpose of strain conservation, allowing the continuation of natural breeding with the safeguard of assisted reproduction available.


10.2196/19570 ◽  
2020 ◽  
Vol 8 (11) ◽  
pp. e19570
Author(s):  
Régine Steegers-Theunissen ◽  
Annemieke Hoek ◽  
Henk Groen ◽  
Annelies Bos ◽  
Grada van den Dool ◽  
...  

Background Approximately 1 in 7 couples experience subfertility, many of whom have lifestyles that negatively affect fertility, such as poor nutrition, low physical activity, obesity, smoking, or alcohol consumption. Reducing lifestyle risk factors prior to pregnancy or assisted reproductive technology treatment contributes to the improvement of reproductive health, but cost-implications are unknown. Objective The goal of this study was to evaluate reproductive, maternal pregnancy, and birth outcomes, as well as the costs of pre-conception lifestyle intervention programs in subfertile couples and obese women undergoing assisted reproductive technology. Methods Using a hypothetical model based on quantitative parameters from published literature and expert opinion, we evaluated the following lifestyle intervention programs: (1) Smarter Pregnancy, an online tool; (2) LIFEstyle, which provides outpatient support for obese women; (3) concurrent use of both Smarter Pregnancy and LIFEstyle for obese women; (4) smoking cessation in men; and (5) a mindfulness mental health support program using group therapy sessions. The model population was based on data from the Netherlands. Results All model-based analyses of the lifestyle interventions showed a reduction in the number of in vitro fertilization, intracytoplasmic sperm injection, or intrauterine insemination treatments required to achieve pregnancy and successful birth for couples in the Netherlands. Smarter Pregnancy was modeled to have the largest increase in spontaneous pregnancy rate (13.0%) and the largest absolute reduction in potential assisted reproductive technology treatments. Among obese subfertile women, LIFEstyle was modeled to show a reduction in the occurrence of gestational diabetes, maternal hypertensive pregnancy complications, and preterm births by 4.4%, 3.8%, and 3.0%, respectively, per couple. Modeled cost savings per couple per year were €41 (US $48.66), €360 (US $427.23), €513 (US $608.80), €586 (US $695.43), and €1163 (US $1380.18) for smoking cessation, mindfulness, Smarter Pregnancy, combined Smarter Pregnancy AND LIFEstyle, and LIFEstyle interventions, respectively. Conclusions Although we modeled the potential impact on reproductive outcomes and costs of fertility treatment rather than collecting real-world data, our model suggests that of the lifestyle interventions for encouraging healthier behaviors, all are likely to be cost effective and appear to have positive effects on reproductive, maternal pregnancy, and birth outcomes. Further real-world data are required to determine the cost-effectiveness of pre-conception lifestyle interventions, including mobile apps and web-based tools that help improve lifestyle, and their effects on reproductive health. We believe that further implementation of the lifestyle app Smarter Pregnancy designed for subfertile couples seeking assistance to become pregnant is likely to be cost-effective and would allow reproductive health outcomes to be collected.


Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 4481-4481
Author(s):  
Amit Patel ◽  
Thomas Stroud ◽  
Danielle Breen ◽  
Ala Taifoor ◽  
Anne Bradshaw ◽  
...  

Abstract Objective: Sperm cryopreservation (sperm banking) is the recommended standard of care for fertility preservation for men with cancer. Men can utilise their sperm for assisted reproductive technology (ART) when they are ready to become fathers. However, the duration of sperm cryopreservation that should be offered to men is unknown. We hypothesised that younger men with cancer require a longer duration of sperm storage before readiness to utilise their samples for ART, compared with older patients. To test this hypothesis, we investigated whether age at sperm harvest predicts the time of sperm storage necessary before ART. Design: A retrospectively analysed cohort study spanning 37 years using prospectively acquired routine clinical data. Setting: A specialist andrology facility in the UK, that provides unlimited storage of sperm as part of NHS treatment free-of-charge to the patient. Participants: Adolescent boys and men with a confirmed diagnosis of cancer were identified by cross-referencing and verifying patient records: Human Fertility & Embryology Authority (HEFA), Department of Andrology, and the NHS Spine Services Portal database, part of the Health and Social Care Information Centre. Main outcome measures: The primary outcome measures were the effect of age on the time from sperm cryopreservation to use for ART, and the specificity and sensitivity of age at predicting the requirement of >10 years sperm storage. Results: 4305 men harvested and cryopreserved their sperm between 1976 and 2013. Men with cancer comprised 3191 and were included in the study. The cancer types that indicated sperm cryopreservation comprised testicular (1130, 35.4%), lymphoma (762, 23.9%), leukaemia (462, 14.5%), and others (838, 26.3%). At sperm harvesting, their median age was 30.3 years (IQR 24.6 to 36.2). Sperm from 217 (6.8%) patients with a median age of 31.3 (IQR 26.5 to 36.7) were utilized for ART after a median of 7.8 years (interquartile range (IQR) 3.5 to 14.3). Increasing age (HR=1.02, 95% CI 1.01 to 1.04, P=0.001), or age decile compared to ≤20 years (P=0.003), was associated with a reduced time interval to sperm utilisation. Age at harvest (P=0.006) was robust to multivariate Cox models (including cancer diagnosis, survival, and year of harvest) and sensitivity analyses. Age ≤30 years at sperm harvest was highly specific (86.1%) and sensitive (65.0%) at predicting the requirement for over ten years of sperm storage prior to ART (AUC 0.82, 95% CI 0.74 to 0.90, P<0.0001). Conclusions: Age at sperm cryopreservation is a key predictor for the likely storage duration necessary prior to ART in men with cancer. A policy of fixed duration of sperm storage may disproportionately deny young patients with cancer access to ART. Policies on sperm storage duration in this population should be reviewed. Disclosures No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document